Biotricity, Inc.

Total Valuation

Biotricity, Inc. carries a market capitalization of 3.02M, placing it among publicly traded companies globally. Its enterprise value stands at 34.97M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Biotricity, Inc. currently has 28.60M shares outstanding.

Valuation Ratios

The price-to-sales ratio is 0.40, and the price-to-book ratio stands at -0.04.

Enterprise Valuation

On an enterprise value basis, Biotricity, Inc. trades at an EV/EBITDA multiple of 20.61 and an EV/FCF ratio of 10.32. The EV/Sales ratio of 2.19 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 20.68 provides insight into valuation relative to core operating earnings.

Financial Position

Biotricity, Inc. maintains a current ratio of 0.16, meaning it holds 0.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -82.10, indicating conservative leverage, while an interest coverage ratio of 0.41 demonstrates limited ability to service its debt obligations.

Financial Efficiency

Stock Price Statistics

Biotricity, Inc.'s stock has declined approximately -77.85571% over the past 52 weeks. The 50-day moving average sits at 0.13, while the 200-day moving average is 0.29.

Income Statement

Over the trailing twelve months, Biotricity, Inc. generated 16.00M in revenue and converted that into -2.40M in net income, yielding earnings per share of -0.09. EBITDA reached 1.70M, while operating income came in at 1.69M.

Balance Sheet

Biotricity, Inc. holds 149,789.00 in cash and equivalents against 27.06M in total debt, resulting in a net debt position of 26.52M. Total book value stands at -142.54M, with working capital of -31.28M providing operational flexibility.

Cash Flow

Biotricity, Inc. produced -718,955.00 in operating cash flow over the past twelve months.

Margins

Biotricity, Inc. operates with a gross margin of 80.94, reflecting its pricing power and cost economics. The operating margin of 10.57 and net profit margin of -15.03 provide insight into operational efficiency.

Dividends & Yields

The company's payout ratio of 22.38 indicates the proportion of earnings distributed to shareholders.

Stock Splits

Biotricity, Inc.'s most recent stock split took place on July 3, 2023 with a 6:1 split ratio.

Scores

Biotricity, Inc. posts an Altman Z-Score of -33.34, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.